van Laarhoven C J, Andriesse G I, Schipper M E, Akkermans L M, van Vroonhoven T J, Gooszen H G
Department of Surgery, University Hospital Utrecht, The Netherlands.
Ann Surg. 1999 Dec;230(6):750-7; discussion 757-8. doi: 10.1097/00000658-199912000-00003.
To evaluate a new surgical procedure, ileoneorectal anastomosis (INRA), in patients with ulcerative colitis (UC) and familial adenomatous polyposis (FAP).
Surgical treatment in UC and FAP aims to resect diseased colonic mucosa and restore oroanal continuity. The ileopouch anal anastomosis achieves this but has a 15% to 35% complication rate, a 10% failure rate, and an unpredictable functional outcome. An alternative surgical technique, INRA, has been developed in which the rectal mucosa is replaced by a vascularized ileal mucosa graft.
Eleven patients underwent an INRA procedure with a temporary diverting ileostomy. Clinical history, repeat endoscopy, histologic examination, and rectal compliance measurements were carried out before and after surgery.
The INRA procedure was technically successful in all patients. Endoscopy showed ingrowth of ileal mucosa in the neorectum, with 100% coverage after 6 weeks. No patient had pelvic sepsis, neorectal-anal or -vaginal fistula, autonomic nerve damage, or fecal incontinence. Neorectal function improved with time. The median 24-hour defecation frequency decreased from 15 (range 9 to 25) to 7 (range 4 to 10) at 11 months follow-up, and the median maximum tolerated volume increased to 157 (range 130 to 225) ml. Anal manometry and electrosensitivity were not affected by the surgery. Histologic biopsy samples after 1 year showed a normal small intestinal mucous membrane, without inflammation or fibrosis.
The combination of a low complication rate and good neorectal function at 1 year is a substantial improvement that justifies extension of the clinical application in patients with UC and FAP.
评估一种新的手术方法——回肠直肠吻合术(INRA),用于溃疡性结肠炎(UC)和家族性腺瘤性息肉病(FAP)患者。
UC和FAP的手术治疗旨在切除病变的结肠黏膜并恢复经口至肛门的连续性。回肠储袋肛管吻合术可实现这一目标,但并发症发生率为15%至35%,失败率为10%,且功能结局不可预测。已开发出另一种手术技术INRA,即用带血管蒂的回肠黏膜移植物替代直肠黏膜。
11例患者接受了INRA手术并进行了暂时性转流性回肠造口术。在手术前后进行了临床病史、重复内镜检查、组织学检查和直肠顺应性测量。
INRA手术在所有患者中技术上均获成功。内镜检查显示回肠黏膜在新直肠内生长,6周后覆盖率达100%。无患者发生盆腔感染、新直肠肛管或阴道瘘、自主神经损伤或大便失禁。新直肠功能随时间改善。随访11个月时,24小时排便频率中位数从15次(范围9至25次)降至7次(范围4至10次),最大耐受容量中位数增至157毫升(范围130至225毫升)。手术未影响肛门测压和电敏感性。1年后的组织学活检样本显示小肠黏膜正常,无炎症或纤维化。
1年时低并发症发生率和良好的新直肠功能相结合是一项重大改进,证明可扩大在UC和FAP患者中的临床应用。